Related references
Note: Only part of the references are listed.Multiplatform Approach for Plasma Proteomics: Complementarity of Olink Proximity Extension Assay Technology to Mass Spectrometry-Based Protein Profiling
Agnese Petrera et al.
JOURNAL OF PROTEOME RESEARCH (2021)
Expression of the Immune Checkpoint Regulators LAG-3 and TIM-3 in Classical Hodgkin Lymphoma
Layal El Halabi et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2021)
Revisiting IL-6 expression in the tumor microenvironment of classical Hodgkin lymphoma
Alex Reza Gholiha et al.
BLOOD ADVANCES (2021)
IL-6 promotes PD-L1 expression in monocytes and macrophages by decreasing protein tyrosine phosphatase receptor type O expression in human hepatocellular carcinoma
Wenjie Zhang et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Analysis of CXCL9, PD1 and PD-L1 mRNA in Stage T1 Non-Muscle Invasive Bladder Cancer and Their Association with Prognosis
Jennifer Kubon et al.
CANCERS (2020)
Roles of IFN-γ in tumor progression and regression: a review
Dragica Jorgovanovic et al.
BIOMARKER RESEARCH (2020)
Epstein-Barr virus-encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B-cell lymphomas
Eleni Anastasiadou et al.
LEUKEMIA (2019)
A targeted proteomics approach reveals a serum protein signature as diagnostic biomarker for resectable gastric cancer
Qiujin Shen et al.
EBIOMEDICINE (2019)
Treating Hodgkin lymphoma in the new millennium: Relapsed and refractory disease
Ann S. LaCasce
HEMATOLOGICAL ONCOLOGY (2019)
Mechanisms regulating PD-L1 expression on tumor and immune cells
Shuming Chen et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Migration Properties Distinguish Tumor Cells of Classical Hodgkin Lymphoma from Anaplastic Large Cell Lymphoma Cells
Olga Goncharova et al.
CANCERS (2019)
Detection of post-translational modifications using solid-phase proximity ligation assay
Felipe Marques Souza de Oliveira et al.
NEW BIOTECHNOLOGY (2018)
The chemokine MCP-1 (CCL2) in the host interaction with cancer: a foe or ally?
Teizo Yoshimura
CELLULAR & MOLECULAR IMMUNOLOGY (2018)
Clinical and Molecular Predictors of PD-L1 Expression in Non-Small-Cell Lung Cancer: Systematic Review and Meta-analysis
Fausto Petrelli et al.
CLINICAL LUNG CANCER (2018)
PD-L1 expression is mainly regulated by interferon gamma associated with JAK-STAT pathway in gastric cancer
Kousaku Mimura et al.
CANCER SCIENCE (2018)
Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
Angel Garcia-Diaz et al.
CELL REPORTS (2017)
Elevated Levels of Interferon-γ Are Associated with High Levels of Epstein-Barr Virus Reactivation in Patients with the Intestinal Type of Gastric Cancer
Maria G. Cardenas-Mondragon et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2017)
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
Nisha Nagarsheth et al.
NATURE REVIEWS IMMUNOLOGY (2017)
High proportions of PD-1+ and PD-L1+ leukocytes in classical Hodgkin lymphoma microenvironment are associated with inferior outcome
Peter Hollander et al.
BLOOD ADVANCES (2017)
The immune microenvironment in Hodgkin lymphoma: T cells, B cells, and immune checkpoints
Santosha Vardhana et al.
HAEMATOLOGICA (2016)
Comparative proteomic profiling of Hodgkin lymphoma cell lines
D. Vergara et al.
MOLECULAR BIOSYSTEMS (2016)
The immune microenvironment in Hodgkin lymphoma: T cells, B cells, and immune checkpoints
Santosha Vardhana et al.
HAEMATOLOGICA (2016)
Mechanism of Action of IL-7 and Its Potential Applications and Limitations in Cancer Immunotherapy
Jianbao Gao et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
A New Initiative on Precision Medicine
Francis S. Collins et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
The prognostic significance of PD-L1 in bladder cancer
Yide Huang et al.
ONCOLOGY REPORTS (2015)
CD68-positive tumor-associated macrophages predict unfavorable treatment outcomes in classical Hodgkin lymphoma in correlation with interim fluorodeoxyglucose-positron emission tomography assessment
Mohamed Touati et al.
LEUKEMIA & LYMPHOMA (2015)
Regulation of Chemokine Expression in the Tumor Microenvironment
Anton V. Gorbachev et al.
CRITICAL REVIEWS IN IMMUNOLOGY (2014)
Homogenous 96-Plex PEA Immunoassay Exhibiting High Sensitivity, Specificity, and Excellent Scalability
Erika Assarsson et al.
PLOS ONE (2014)
Baseline serum TARC levels predict therapy outcome in patients with Hodgkin lymphoma
Maike Sauer et al.
AMERICAN JOURNAL OF HEMATOLOGY (2013)
Defining characteristics of classical Hodgkin lymphoma microenvironment T-helper cells
Paul Greaves et al.
BLOOD (2013)
Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trial
King L. Tan et al.
BLOOD (2012)
Gene expression profiling of microdissected Hodgkin Reed-Sternberg cells correlates with treatment outcome in classical Hodgkin lymphoma
Christian Steidl et al.
BLOOD (2012)
Interleukin-6 signaling pathway in targeted therapy for cancer
Yuqi Guo et al.
CANCER TREATMENT REVIEWS (2012)
Role of Immune Escape Mechanisms in Hodgkin's Lymphoma Development and Progression: A Whole New World with Therapeutic Implications
Luis de la Cruz-Merino et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2012)
Constitutive AP-1 Activity and EBV Infection Induce PD-L1 in Hodgkin Lymphomas and Posttransplant Lymphoproliferative Disorders: Implications for Targeted Therapy
Michael R. Green et al.
CLINICAL CANCER RESEARCH (2012)
Antibody Colocalization Microarray: A Scalable Technology for Multiplex Protein Analysis in Complex Samples
M. Pla-Roca et al.
MOLECULAR & CELLULAR PROTEOMICS (2012)
The human IL-7 receptor gene: Deletions, polymorphisms and mutations
Renata I. Mazzucchelli et al.
SEMINARS IN IMMUNOLOGY (2012)
Personalized Medicine and Cancer
Mukesh Verma
JOURNAL OF PERSONALIZED MEDICINE (2012)
HDAC11 plays an essential role in regulating OX40 ligand expression in Hodgkin lymphoma
Daniela Buglio et al.
BLOOD (2011)
Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma
Michael R. Green et al.
BLOOD (2010)
The classical Hodgkin's lymphoma microenvironment and its role in promoting tumour growth and immune escape
Donatella Aldinucci et al.
JOURNAL OF PATHOLOGY (2010)
Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma
Christian Steidl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Functional coexpression of Interleukin (IL)-7 and its receptor (IL-7R) on Hodgkin and Reed-Sternberg cells: Involvement of IL-7 in tumor cell growth and microenvironmental interactions of Hodgkin's lymphoma
Lara Cattaruzza et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Serum chemokine levels in Hodgkin lymphoma patients: highly increased levels of CCL17 and CCL22
Marijke Niens et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Preclinical Characterization of SGN-70, a Humanized Antibody Directed against CD70
Julie A. McEarchern et al.
CLINICAL CANCER RESEARCH (2008)
Treatment of Hodgkin lymphoma: the past, present, and future
Andrew M. Evens et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2008)
Proteomics analysis of Hodgkin lymphoma: identification of new players involved in the cross-talk between HRS cells and infiltrating lymphocytes
Yue Ma et al.
BLOOD (2008)
Comprehensive identification of proteins in Hodgkin lymphoma-derived Reed-Sternberg cells by LC-MS/MS
Jeremy C. Wallentine et al.
LABORATORY INVESTIGATION (2007)
Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen-specific CD8+ T-cell function in Hodgkin lymphoma patients
Maher K. Gandhi et al.
BLOOD (2006)
Protein expression pattern distinguishes different lymphoid neoplasms
K Fujii et al.
PROTEOMICS (2005)
Wnt-7a up-regulates matrix metalloproteinase-12 expression and promotes cell proliferation in corneal epithelial cells during wound healing
J Lyu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The role of cytokines in classical Hodgkin lymphoma
BF Skinnider et al.
BLOOD (2002)
Common and differential chemokine expression patterns in RS cells of NLP, EBV positive and negative classical Hodgkin lymphomas
EM Maggio et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
The role of interleukin 13 in classical Hodgkin lymphoma
BF Skinnider et al.
LEUKEMIA & LYMPHOMA (2002)
Protein detection using proximity-dependent DNA ligation assays
S Fredriksson et al.
NATURE BIOTECHNOLOGY (2002)
Chemokines, cytokines and their receptors in Hodgkin's lymphoma cell lines and tissues
E Maggio et al.
ANNALS OF ONCOLOGY (2002)
Interleukin-13 and interleukin-13 receptor in Hodgkin's disease: possible autocrine mechanism and involvement in fibrosis
K Ohshima et al.
HISTOPATHOLOGY (2001)
CC chemokines and the receptors CCR3 and CCR5 are differentially expressed in the nonneoplastic leukocytic infiltrates of Hodgkin disease
C Buri et al.
BLOOD (2001)
Interleukin 13 and interleukin 13 receptor are frequently expressed by Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma
BF Skinnider et al.
BLOOD (2001)